Noncoding RNAs in breast cancer.

The mammalian transcriptome has recently been revealed to encompass a large number of noncoding RNAs (ncRNAs) that play a variety of important regulatory roles in gene expression and other biological processes. MicroRNAs (miRNAs), the best studied of the short noncoding RNAs (sncRNAs), have been extensively characterized with regard to their biogenesis, function and importance in tumorigenesis. Another class of sncRNAs called piwi-interacting RNAs (piRNAs) has also gained attention recently in cancer research owing to their critical role in stem cell regulation. Long noncoding RNAs (lncRNAs) of >200 nucleotides in length have recently emerged as key regulators of developmental processes, including mammary gland development. lncRNA dysregulation has also been implicated in the development of various cancers, including breast cancer. In this review, we describe and discuss the roles of sncRNAs (including miRNAs and piRNAs) and lncRNAs in the initiation and progression of breast tumorigenesis, with a focus on outlining the molecular mechanisms of oncogenic and tumor-suppressor ncRNAs. Moreover, the current and potential future applications of ncRNAs to clinical breast cancer research are also discussed, with an emphasis on ncRNA-based diagnosis, prognosis and future therapeutics.

[1]  Jun Zeng,et al.  MiR-204-5p/Six1 feedback loop promotes epithelial–mesenchymal transition in breast cancer , 2016, Tumor Biology.

[2]  Shu-peng Chen,et al.  MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets , 2015, BMC Cancer.

[3]  Tongzhang Zheng,et al.  PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome. , 2015, Carcinogenesis.

[4]  Jindan Yu,et al.  LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer , 2015, Oncogene.

[5]  J. Lennerz,et al.  Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition , 2015, Nature Communications.

[6]  P. Ismail,et al.  MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment. , 2015, Pharmacological research.

[7]  Jian Zhu,et al.  Upregulation of miR-195 enhances the radiosensitivity of breast cancer cells through the inhibition of BCL-2. , 2015, International journal of clinical and experimental medicine.

[8]  X. Shu,et al.  Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes , 2015, Breast Cancer Research and Treatment.

[9]  M Callari,et al.  miR-30e* is an independent subtype-specific prognostic marker in breast cancer , 2015, British Journal of Cancer.

[10]  K. Watabe,et al.  Roles of lncRNA in breast cancer. , 2015, Frontiers in bioscience.

[11]  S. Hirota,et al.  Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer. , 2015, Clinical breast cancer.

[12]  R. Ma,et al.  Identification of microRNAs in Nipple Discharge as Potential Diagnostic Biomarkers for Breast Cancer , 2015, Annals of Surgical Oncology.

[13]  Jin Gao,et al.  Prognostic value of miR-106b expression in breast cancer patients. , 2015, The Journal of surgical research.

[14]  E. Yagüe,et al.  miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer , 2015, Breast Cancer Research and Treatment.

[15]  O. Shaker,et al.  Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females. , 2015, Gene.

[16]  Gerta Rücker,et al.  Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker , 2015, BMC Cancer.

[17]  Shao-Chun Wang,et al.  Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR , 2015, Oncotarget.

[18]  S. Vacher,et al.  ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels , 2015, British Journal of Cancer.

[19]  L. Hofseth,et al.  A novel chemopreventive strategy based on therapeutic microRNAs produced in plants , 2015, Cell Research.

[20]  Yong Li,et al.  MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1 , 2015, Journal of cellular and molecular medicine.

[21]  Weidong Wei,et al.  miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer. , 2015, Cancer letters.

[22]  S. Agarwal,et al.  Quantitative assessment of miR34a as an independent prognostic marker in breast cancer , 2014, British Journal of Cancer.

[23]  Shinichi Nakagawa,et al.  The long noncoding RNA Neat1 is required for mammary gland development and lactation , 2014, RNA.

[24]  Xu Ma,et al.  MiR‐185 is involved in human breast carcinogenesis by targeting Vegfa , 2014, FEBS letters.

[25]  F Buffa,et al.  Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival , 2014, Oncogene.

[26]  Eugenia G. Giannopoulou,et al.  The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer , 2014, Nature Communications.

[27]  Qiurong Li,et al.  Prognostic and Biological Significance of MicroRNA-127 Expression in Human Breast Cancer , 2014, Disease markers.

[28]  M. Askarian-Amiri,et al.  Keeping abreast with long non-coding RNAs in mammary gland development and breast cancer , 2014, Front. Genet..

[29]  Xiaoping Liu,et al.  miR-185 Suppresses Tumor Proliferation by Directly Targeting E2F6 and DNMT1 and Indirectly Upregulating BRCA1 in Triple-Negative Breast Cancer , 2014, Molecular Cancer Therapeutics.

[30]  S. Bhattacharya,et al.  Breast cancer stem cells, EMT and therapeutic targets. , 2014, Biochemical and biophysical research communications.

[31]  Qun Zhou,et al.  lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6 , 2014, Molecular Cancer Research.

[32]  Hongwei Liang,et al.  miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer , 2014, Molecular Cancer.

[33]  Maria Ravo,et al.  RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer , 2014, Oncotarget.

[34]  G. Meister,et al.  Import routes and nuclear functions of Argonaute and other small RNA-silencing proteins. , 2014, Trends in biochemical sciences.

[35]  Tao Xi,et al.  FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity , 2014, FEBS letters.

[36]  Yul Ri Chung,et al.  MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer , 2014, Breast Cancer Research and Treatment.

[37]  C. Bracken,et al.  MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways , 2014, Oncogene.

[38]  K. Abdul,et al.  Functional significance of long non-coding RNAs in breast cancer , 2014, Breast Cancer.

[39]  Lorenzo Farina,et al.  Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer , 2014, BMC Systems Biology.

[40]  Yang Zhang,et al.  A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. , 2014, Cancer research.

[41]  Stephen L. Abrams,et al.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention , 2014, Oncotarget.

[42]  Jian Jin,et al.  MiR‐489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway , 2014, FEBS letters.

[43]  Qiang Hu,et al.  Circulating miR-148b and miR-133a as biomarkers for breast cancer detection , 2014, Oncotarget.

[44]  Y. Chae,et al.  Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer. , 2014, Anticancer research.

[45]  Qun Zhou,et al.  Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer , 2014, Oncogene.

[46]  S. Zhong,et al.  Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs , 2014, PloS one.

[47]  T. Zhu,et al.  Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2 , 2014, Breast Cancer Research.

[48]  Weiying Zhou,et al.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. , 2014, Cancer cell.

[49]  L. Tang,et al.  MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression , 2014, PloS one.

[50]  Guanqing Ou,et al.  Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression , 2014, Nature Medicine.

[51]  Lin Fang,et al.  miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer. , 2014, Oncology reports.

[52]  M. Leary,et al.  Genetic and epigenetic aspects of breast cancer progression and therapy. , 2014, Anticancer research.

[53]  A. Masamune,et al.  MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX. , 2014, Cellular signalling.

[54]  M. J. van de Vijver,et al.  Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets , 2014, Genome Biology.

[55]  E. Cuppen,et al.  Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes , 2014, Genome Biology.

[56]  M. Žegarac,et al.  Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information , 2014, Clinical Medicine Insights. Oncology.

[57]  Y. Mo,et al.  Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) , 2014, Cell Death and Disease.

[58]  Jian-xin Gao,et al.  Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[59]  Qun Zhou,et al.  Characterization of a Stem-like Subpopulation in Basal-like Ductal Carcinoma in Situ (DCIS) Lesions* , 2013, The Journal of Biological Chemistry.

[60]  Matheus C. Bürger,et al.  Brief Report: The lincRNA Hotair Is Required for Epithelial‐to‐Mesenchymal Transition and Stemness Maintenance of Cancer Cell Lines , 2013, Stem cells.

[61]  H. Zhang,et al.  The expression of stem cell protein Piwil2 and piR-932 in breast cancer. , 2013, Surgical oncology.

[62]  P. Fortina,et al.  Cyclin D1 Induction of Dicer Governs MicroRNA Processing and Expression in Breast Cancer , 2013, Nature Communications.

[63]  Yuntao Xie,et al.  miR-127 Regulates Cell Proliferation and Senescence by Targeting BCL6 , 2013, PloS one.

[64]  M. Larsen,et al.  Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer , 2013, Breast Cancer Research and Treatment.

[65]  Michael Golatta,et al.  Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer , 2013, PloS one.

[66]  Kiranmai Gumireddy,et al.  Identification of a long non‐coding RNA‐associated RNP complex regulating metastasis at the translational step , 2013, The EMBO journal.

[67]  Lin Zhao,et al.  MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). , 2013, Cancer letters.

[68]  L. Holmberg,et al.  Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control , 2013, BMC Genomics.

[69]  Masayuki Matsui,et al.  Promoter RNA links transcriptional regulation of inflammatory pathway genes , 2013, Nucleic acids research.

[70]  Luzhe Sun,et al.  Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer , 2013, Oncogene.

[71]  Daniel R. Caffrey,et al.  A Long Noncoding RNA Mediates Both Activation and Repression of Immune Response Genes , 2013, Science.

[72]  Q. Shi,et al.  Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. , 2013, Oncology reports.

[73]  M. Behlke,et al.  Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide Modifier , 2013, Molecular therapy. Nucleic acids.

[74]  Ç. Gerçel-Taylor,et al.  The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids , 2013, Front. Genet..

[75]  Ugo Ala,et al.  MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling , 2013, Cell.

[76]  Y. Okada,et al.  HMGA2 is a driver of tumor metastasis. , 2013, Cancer research.

[77]  C. Gebeshuber,et al.  miR-100 suppresses IGF2 and inhibits breast tumorigenesis by interfering with proliferation and survival signaling , 2013, Oncogene.

[78]  P. Tan,et al.  Identification of Circulating MicroRNA Signatures for Breast Cancer Detection , 2013, Clinical Cancer Research.

[79]  P. Perumal,et al.  Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients. , 2013, Indian journal of biochemistry & biophysics.

[80]  Jindan Yu,et al.  BRCA1 is a negative modulator of the PRC2 complex , 2013, The EMBO journal.

[81]  M. Ferrari,et al.  Delivery of gene silencing agents for breast cancer therapy , 2013, Breast Cancer Research.

[82]  Andrea Sottoriva,et al.  The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.

[83]  Yan Wang,et al.  EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2 , 2013, Nature.

[84]  Stefano Volinia,et al.  Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer , 2013, Proceedings of the National Academy of Sciences.

[85]  M. Hou,et al.  Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. , 2013, Biochimica et biophysica acta.

[86]  S. Diederichs,et al.  MALAT1 — a paradigm for long noncoding RNA function in cancer , 2013, Journal of Molecular Medicine.

[87]  Howard Y. Chang,et al.  Long Noncoding RNAs: Cellular Address Codes in Development and Disease , 2013, Cell.

[88]  J. Mattick,et al.  Structure and function of long noncoding RNAs in epigenetic regulation , 2013, Nature Structural &Molecular Biology.

[89]  M. Gorospe,et al.  Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB , 2013, PLoS genetics.

[90]  C. Croce,et al.  Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status , 2013, PLoS genetics.

[91]  Cristina Rodríguez-Padilla,et al.  Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers , 2013, Disease markers.

[92]  Wei Zhang,et al.  Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer , 2013, Medical Oncology.

[93]  D. Spector,et al.  The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. , 2013, Cancer research.

[94]  Xun Zhu,et al.  MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis. , 2013, The Journal of clinical investigation.

[95]  Bei Zhang,et al.  The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers , 2013, Tumor Biology.

[96]  Z. Werb,et al.  GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression , 2013, Nature Cell Biology.

[97]  T. Hirose,et al.  Paraspeckle formation during the biogenesis of long non-coding RNAs , 2013, RNA biology.

[98]  Sun-Mi Park,et al.  Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. , 2013, Cancer cell.

[99]  Ava Kwong,et al.  Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection , 2013, PloS one.

[100]  William P Schiemann,et al.  TGF-β upregulates miR-181a expression to promote breast cancer metastasis. , 2013, The Journal of clinical investigation.

[101]  J. Wrana,et al.  Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration , 2012, Cell.

[102]  J. Baak,et al.  Validation of Expression Patterns for Nine miRNAs in 204 Lymph-Node Negative Breast Cancers , 2012, PloS one.

[103]  M. Siomi,et al.  Biology of PIWI-interacting RNAs: new insights into biogenesis and function inside and outside of germlines. , 2012, Genes & development.

[104]  R. Spizzo,et al.  Long non-coding RNAs and cancer: a new frontier of translational research? , 2012, Oncogene.

[105]  Laoighse Mulrane,et al.  miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro , 2012, Clinical Cancer Research.

[106]  Yingjian Chen,et al.  Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer , 2012, Journal of Cancer Research and Clinical Oncology.

[107]  J. Silke,et al.  The Tumor Suppressor PTEN Is Exported in Exosomes and Has Phosphatase Activity in Recipient Cells , 2012, Science Signaling.

[108]  Axel Benner,et al.  Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer , 2012, Clinical Cancer Research.

[109]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[110]  Lijuan Guo,et al.  Decreased serum miR-181a is a potential new tool for breast cancer screening. , 2012, International journal of molecular medicine.

[111]  I. Ellis,et al.  Loss of Dicer expression is associated with breast cancer progression and recurrence , 2012, Breast Cancer Research and Treatment.

[112]  Qiaoyan Li,et al.  miR-7 and miR-218 epigenetically control tumor suppressor genes RASSF1A and Claudin-6 by targeting HoxB3 in breast cancer. , 2012, Biochemical and biophysical research communications.

[113]  Zuhong Lu,et al.  Analysis of serum genome-wide microRNAs for breast cancer detection. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[114]  K. Nakai,et al.  Genome-Wide Analysis of DNA Methylation and Expression of MicroRNAs in Breast Cancer Cells , 2012, International journal of molecular sciences.

[115]  Carlos Caldas,et al.  Biological and prognostic associations of miR‐205 and let‐7b in breast cancer revealed by in situ hybridization analysis of micro‐RNA expression in arrays of archival tumour tissue , 2012, The Journal of pathology.

[116]  G. Kollias,et al.  Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer. , 2012, Cancer cell.

[117]  Christopher J. Cheng,et al.  Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma , 2012, Proceedings of the National Academy of Sciences.

[118]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[119]  X. Wang,et al.  Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer , 2012, The Journal of international medical research.

[120]  D. Birnbaum,et al.  MicroRNA93 Regulates Proliferation and Differentiation of Normal and Malignant Breast Stem Cells , 2012, PLoS genetics.

[121]  Qing Xu,et al.  MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF , 2012, Cell cycle.

[122]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[123]  Chunxiao Liu,et al.  Rab21 attenuates EGF-mediated MAPK signaling through enhancing EGFR internalization and degradation. , 2012, Biochemical and biophysical research communications.

[124]  Yong Li,et al.  A novel miR‐155/miR‐143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells , 2012, The EMBO journal.

[125]  A. Amano,et al.  BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex , 2012, The Journal of cell biology.

[126]  Chun-Wen Cheng,et al.  MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer , 2012, Breast Cancer Research and Treatment.

[127]  Jason I. Herschkowitz,et al.  Noncoding RNAs Involved in Mammary Gland Development and Tumorigenesis: There’s a Long Way to Go , 2012, Journal of Mammary Gland Biology and Neoplasia.

[128]  Hua Li,et al.  miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w. , 2012, Experimental and therapeutic medicine.

[129]  Klaus Pantel,et al.  Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients , 2012, Breast Cancer Research and Treatment.

[130]  J. Rinn,et al.  Modular regulatory principles of large non-coding RNAs , 2012, Nature.

[131]  C. Croce,et al.  Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA , 2012, Proceedings of the National Academy of Sciences.

[132]  S. Siddiqi,et al.  Piwis and piwi‐interacting RNAs in the epigenetics of cancer , 2012, Journal of cellular biochemistry.

[133]  Jia Cheng,et al.  piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. , 2012, Cancer letters.

[134]  B. White,et al.  ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer , 2012, Trends in Endocrinology & Metabolism.

[135]  D. Warburton,et al.  MIR-99a and MIR-99b Modulate TGF-β Induced Epithelial to Mesenchymal Plasticity in Normal Murine Mammary Gland Cells , 2012, PloS one.

[136]  Susan A Kadlubar,et al.  Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells , 2012, BMC Cancer.

[137]  H. Ford,et al.  The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer , 2012, Oncogene.

[138]  M. Esteller Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[139]  Michael C. Ostrowski,et al.  Reprogramming of the Tumor Microenvironment by Stromal Pten-regulated miR-320 , 2011, Nature Cell Biology.

[140]  P. Leedman,et al.  Steroid Receptor RNA Activator - A nuclear receptor coregulator with multiple partners: Insights and challenges. , 2011, Biochimie.

[141]  A. Chinnaiyan,et al.  The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.

[142]  Libing Song,et al.  miR-18a Impairs DNA Damage Response through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase , 2011, PloS one.

[143]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[144]  Cole Trapnell,et al.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.

[145]  Hyunsuk Shim,et al.  Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTEN , 2011, Pharmaceutical Research.

[146]  J. Rinn,et al.  lincRNAs act in the circuitry controlling pluripotency and differentiation , 2011, Nature.

[147]  Volker Hovestadt,et al.  Molecular and Cellular Pathobiology MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing , 2011 .

[148]  Ru-Fang Yeh,et al.  TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer , 2011, Science Signaling.

[149]  Wenlin Huang,et al.  miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. , 2011, Cancer research.

[150]  B. Katzenellenbogen,et al.  Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance , 2011, Oncogene.

[151]  Fátima Sánchez-Cabo,et al.  Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells , 2011, Nature communications.

[152]  Jining Lu,et al.  Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer , 2011, Breast Cancer Research.

[153]  Meng Li,et al.  MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways , 2011, Oncogene.

[154]  Steven J. Greco,et al.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.

[155]  Bing-Hua Jiang,et al.  Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer , 2011, Clinical Cancer Research.

[156]  Shu Ichihara,et al.  Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists , 2011, Modern Pathology.

[157]  M. Gorospe,et al.  miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. , 2011, Molecular cell.

[158]  Yuan Shen,et al.  Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2 , 2011, Molecular and Cellular Biochemistry.

[159]  D. Sgroi,et al.  The molecular pathology of breast cancer progression , 2011, The Journal of pathology.

[160]  Libing Song,et al.  Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a , 2010, PloS one.

[161]  H. Zhang,et al.  microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. , 2010, Oncology reports.

[162]  Yang Yu,et al.  Transforming growth factor β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM , 2010, Oncogene.

[163]  Kevin Struhl,et al.  STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. , 2010, Molecular cell.

[164]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[165]  J. Reis-Filho,et al.  Breast cancer precursors revisited: molecular features and progression pathways , 2010, Histopathology.

[166]  M. Gerstein,et al.  Annotating non-coding regions of the genome , 2010, Nature Reviews Genetics.

[167]  Michael J Kerin,et al.  Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. , 2010, The oncologist.

[168]  F. Ferrari,et al.  A MicroRNA Targeting Dicer for Metastasis Control , 2010, Cell.

[169]  Hyunsuk Shim,et al.  Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. , 2010, Biochemical pharmacology.

[170]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[171]  G. Chrousos,et al.  Noncoding RNA Gas5 Is a Growth Arrest– and Starvation-Associated Repressor of the Glucocorticoid Receptor , 2010, Science Signaling.

[172]  G. Mills,et al.  miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells , 2010, Cell Death and Differentiation.

[173]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[174]  Z. Shao,et al.  Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer , 2009, Oncogene.

[175]  A. Thakur,et al.  Expression profile of microRNAs in c-Myc induced mouse mammary tumors , 2009, Breast Cancer Research and Treatment.

[176]  Ricky T. Tong,et al.  Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. , 2009, Molecular cell.

[177]  Xudong Dai,et al.  MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT , 2009, Cell cycle.

[178]  Michael F. Clarke,et al.  Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells , 2009, Cell.

[179]  S. Srikantan,et al.  HuR recruits let-7/RISC to repress c-Myc expression. , 2009, Genes & development.

[180]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[181]  Olivier Voinnet,et al.  The long and the short of noncoding RNAs. , 2009, Current opinion in cell biology.

[182]  Robert A. Weinberg,et al.  A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .

[183]  H. Hollema,et al.  Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma , 2009, BMC Cancer.

[184]  Jing Li,et al.  miR-145 inhibits breast cancer cell growth through RTKN. , 2009, International journal of oncology.

[185]  J. Kawai,et al.  Tiny RNAs associated with transcription start sites in animals , 2009, Nature Genetics.

[186]  Christopher J. Lee,et al.  A transcriptional sketch of a primary human breast cancer by 454 deep sequencing , 2009, BMC Genomics.

[187]  A. Armugam,et al.  MicroRNAs: biogenesis, function and applications. , 2009, Current opinion in molecular therapeutics.

[188]  John N. Hutchinson,et al.  An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. , 2009, Molecular cell.

[189]  Michael F. Lin,et al.  Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals , 2009, Nature.

[190]  M. Mourtada-Maarabouni,et al.  GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer , 2009, Oncogene.

[191]  Z. Xuan,et al.  Deregulation of Scribble Promotes Mammary Tumorigenesis and Reveals a Role for Cell Polarity in Carcinoma , 2008, Cell.

[192]  Domenico Coppola,et al.  MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer* , 2008, Journal of Biological Chemistry.

[193]  Tyler E. Miller,et al.  MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦ , 2008, Journal of Biological Chemistry.

[194]  Carme Camps,et al.  MicroRNA-10b and breast cancer metastasis , 2008, Nature.

[195]  P. Sætrom,et al.  MicroRNA-directed transcriptional gene silencing in mammalian cells , 2008, Proceedings of the National Academy of Sciences.

[196]  Olga Kovalchuk,et al.  Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin , 2008, Molecular Cancer Therapeutics.

[197]  T. Wurdinger,et al.  MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.

[198]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[199]  Carme Camps,et al.  hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer , 2008, Clinical Cancer Research.

[200]  A. Krogh,et al.  Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[201]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[202]  J. Lieberman,et al.  let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.

[203]  D. Haber,et al.  Dual Role for Argonautes in MicroRNA Processing and Posttranscriptional Regulation of MicroRNA Expression , 2007, Cell.

[204]  M. Teichmann,et al.  The expanding RNA polymerase III transcriptome. , 2007, Trends in genetics : TIG.

[205]  Eugene Berezikov,et al.  Mammalian mirtron genes. , 2007, Molecular cell.

[206]  D. Bartel,et al.  Intronic microRNA precursors that bypass Drosha processing , 2007, Nature.

[207]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[208]  P. Stadler,et al.  RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive Transcription , 2007, Science.

[209]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[210]  V. Kim,et al.  Processing of intronic microRNAs , 2007, The EMBO journal.

[211]  John N. Hutchinson,et al.  A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains , 2007, BMC Genomics.

[212]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[213]  T. Dalmay,et al.  MicroRNAs and the hallmarks of cancer , 2006, Oncogene.

[214]  P. Mullan,et al.  The role of BRCA1 in transcriptional regulation and cell cycle control , 2006, Oncogene.

[215]  V. Kim,et al.  Small RNAs just got bigger: Piwi-interacting RNAs (piRNAs) in mammalian testes. , 2006, Genes & development.

[216]  M. Kiefmann,et al.  Inhibitory effect of naked neural BC1 RNA or BC200 RNA on eukaryotic in vitro translation systems is reversed by poly(A)-binding protein (PABP). , 2005, Journal of molecular biology.

[217]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[218]  Philipp Kapranov,et al.  Examples of the complex architecture of the human transcriptome revealed by RACE and high-density tiling arrays. , 2005, Genome research.

[219]  D. McDonald,et al.  Cellular abnormalities of blood vessels as targets in cancer. , 2005, Current opinion in genetics & development.

[220]  Thomas E. Royce,et al.  Global Identification of Human Transcribed Sequences with Genome Tiling Arrays , 2004, Science.

[221]  A. Iacoangeli,et al.  BC200 RNA in invasive and preinvasive breast cancer. , 2004, Carcinogenesis.

[222]  A. Bradley,et al.  Identification of mammalian microRNA host genes and transcription units. , 2004, Genome research.

[223]  J. M. Thomson,et al.  Argonaute2 Is the Catalytic Engine of Mammalian RNAi , 2004, Science.

[224]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[225]  R. Lanz,et al.  Steroid Receptor RNA Activator Stimulates Proliferation as Well as Apoptosis In Vivo , 2003, Molecular and Cellular Biology.

[226]  V. Kim,et al.  The nuclear RNase III Drosha initiates microRNA processing , 2003, Nature.

[227]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[228]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[229]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[230]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[231]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[232]  H Buerger,et al.  Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes , 1999, The Journal of pathology.

[233]  Helmut Dotzlaw,et al.  Expression of the steroid receptor RNA activator in human breast tumors. , 1999, Cancer research.

[234]  Neil J McKenna,et al.  A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex , 1999, Cell.

[235]  C. Poremba,et al.  Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways , 1999, The Journal of pathology.

[236]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[237]  T. Hirose,et al.  Architectural RNAs (arcRNAs): A class of long noncoding RNAs that function as the scaffold of nuclear bodies. , 2016, Biochimica et biophysica acta.

[238]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[239]  G. Yousef,et al.  Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up. , 2014, Clinical chemistry.

[240]  Zheng-sheng Wu,et al.  Prognostic significance of let-7b expression in breast cancer and correlation to its target gene of BSG expression , 2013, Medical Oncology.

[241]  Yanyan Li,et al.  microRNA-210 as a prognostic factor in patients with breast cancer: meta-analysis. , 2013, Cancer biomarkers : section A of Disease markers.

[242]  Sota Asaga,et al.  Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. , 2011, Clinical chemistry.

[243]  D. Peeper,et al.  Metastasis mechanisms. , 2009, Biochimica et biophysica acta.

[244]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2008, Nature.